‌

US Patent 7262279 Lactoferrin in the treatment of diabetes mellitus

Patent 7262279 was granted and assigned to AGENNIX, INC. on August, 2007 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent

Patent attributes

Current Assignee

AGENNIX, INC.

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

72622790

Patent Inventor Names

Atul Varadhachary0

Jose Engelmayer0

Date of Patent

August 28, 2007

Patent Application Number

114016670

Date Filed

April 11, 2006

Patent Primary Examiner

‌

Chih-Min Kam

Patent abstract

The present invention relates to methods of using a composition of lactoferrin for the treatment of diabetes mellitus as manifested by a reduction in the levels of serum glucose, blood pressure, obesity, or glycosylated hemoglobin (HbA1c).

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7262279 Lactoferrin in the treatment of diabetes mellitus

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API